At A Glance

Name: Michael Pawlak

Age: 42

Position: Director of Protein Microarrays, Zeptosens, Switzerland

Background: Investigator, Bioanalytical Research Department, Ciba Pharma, later merged into Novartis Pharma, 1994 to 1999.

Postdoc, Swiss Federal Institute of Technology, Lausanne, Switzerland, 1991-1994

PhD in biophysical chemistry, Biocenter, University in Basel, Switzerland, 1988-1991.


How did you get into studying cell signaling and high-throughput protein profiling?

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.

Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.